|
1 Indications And Usage Norditropin Is A Recombinant Human Growth Hormone Indicated For: • Pediatric : Treatment Of Pediatric Patients With Growth Failure Due To Inadequate Secretion Of Endogenous Growth Hormone (Gh), Short Stature Associated With Noonan Syndrome, Short Stature Associated With Turner Syndrome, Short Stature Born Small For Gestational Age (Sga) With No Catch-Up Growth By Age 2 To 4 Years, Idiopathic Short Stature (Iss), And Growth Failure Due To Prader-Willi Syndrome ( 1.1 ) • Adult : Replacement Of Endogenous Gh In Adults With Growth Hormone Deficiency ( 1.2 ) 1.1 Pediatric Patients Norditropin Is Indicated For The Treatment Of Pediatric Patients With: • Growth Failure Due To Inadequate Secretion Of Endogenous Growth Hormone (Gh), • Short Stature Associated With Noonan Syndrome, • Short Stature Associated With Turner Syndrome, • Short Stature Born Small For Gestational Age (Sga) With No Catch-Up Growth By Age 2 Years To 4 Years Of Age, • Idiopathic Short Stature (Iss), Height Standard Deviation Score (Sds) <-2.25, And Associated With Growth Rates Unlikely To Permit Attainment Of Adult Height In The Normal Range, • Growth Failure Due To Prader-Willi Syndrome (Pws). 1.2 Adult Patients Norditropin Is Indicated For The Replacement Of Endogenous Gh In Adults With Growth Hormone Deficiency (Ghd)
|